Left bundle branch area pacing in children: case series
- PMID: 39935814
- PMCID: PMC11811521
- DOI: 10.1093/ehjcr/ytaf020
Left bundle branch area pacing in children: case series
Abstract
Background: Left bundle branch area pacing (LBBAP) is a new concept that provides physiological pacing with a narrow QRS duration. Recently published data suggest that LBBAP may prevent deleterious effects of right ventricular pacing, namely pacemaker-induced cardiomyopathy, especially in patients with expected high ventricular pacing burden, which may be of particular importance in children.
Case summary: Herein, we report successful implantation of Medtronic SelectSecure (Model 3830, Medtronic Inc.) right ventricle electrode in the region of left bundle branch area in three consecutive children (two 16-year-old and one 8-year-old). Indication for pacemaker implantation was third-degree atrioventricular block in all cases. Implantations were performed under general anaesthesia, and there were no acute complications. During the median follow-up of 6 months, there were no adverse events and the electrical parameters of the device remained stable.
Discussion: Compared with adult patients, implantation of pacemakers in children may still be challenging, not only because of smaller body size but also due to continuing growth and a higher rate of lead and device-related complications. We have demonstrated that implantation of LBBAP in children is feasible and could be worth considering, particularly in patients with expected high ventricular pacing burden. Further studies are needed to assess the efficacy and safety of LBBAP in children during long-term observation.
Keywords: Case series; Children; Conduction system pacing; Left bundle branch area pacing; Pacing.
© The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology.
Conflict of interest statement
Conflict of interest: E.J.-P.—consultant fees from Medtronic, Biotronik, Abbott, and Boston Scientific; M.M.—consultant fees from Medtronic, Biotronik, Abbott, and Boston Scientific; O.K.—consultant fees from Medtronic, Biotronik, Abbott, and Boston Scientific; Z.K.—speaker bureaus for Bayer, BMS/Pfizer, Boehringer Ingelheim, Elli Lilly, and Abbott; R.L.—funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement number 847999. Other authors—no conflict of interests reported.
Figures
References
-
- Kiehl EL, Makki T, Kumar R, Gumber D, Kwon DH, Rickard JW, et al. . Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function. Heart Rhythm 2016;13:2272–2278. - PubMed
-
- Khurshid S, Epstein AE, Verdino RJ, Lin D, Goldberg LR, Marchlinski FE, et al. . Incidence and predictors of right ventricular pacing-induced cardiomyopathy. Heart Rhythm 2014;11:1619–1625. - PubMed
-
- Burri H, Jastrzebski M, Cano Ó, Čurila K, de Pooter J, Huang W, et al. . EHRA clinical consensus statement on conduction system pacing implantation: endorsed by the Asia Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS), and Latin American Heart Rhythm Society (LAHRS). Europace 2023;25:1208–1236. - PMC - PubMed
-
- Huang W, Su L, Wu S, Xu L, Xiao F, Zhou X, et al. . A novel pacing strategy with low and stable output: pacing the left bundle branch immediately beyond the conduction block. Can J Cardiol 2017;33:1736.e1–1736.e3. - PubMed
Publication types
LinkOut - more resources
Full Text Sources